Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,604,030
-
Share change
-
+2,143,733
-
Total reported value
-
$400,575,953
-
Put/Call ratio
-
116%
-
Price per share
-
$16.29
-
Number of holders
-
137
-
Value change
-
+$35,473,049
-
Number of buys
-
60
-
Number of sells
-
69
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q4 2021
As of 31 Dec 2021,
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,604,030 shares.
The largest 10 holders included
STATE STREET CORP, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Samsara BioCapital, LLC, MACQUARIE GROUP LTD, JACOBS LEVY EQUITY MANAGEMENT, INC, MILLENNIUM MANAGEMENT LLC, and TWO SIGMA ADVISERS, LP.
This page lists
137
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.